Posts in the “Collaboration Collaboration” category:

Circulating tumor cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

Posted by Samantha Powell on September 23rd, 2014 |

EKF Diagnostics, the global diagnostics company, announces that it has entered into a two year research collaboration with Massachusetts General Hospital (MGH), a global leader in successfully bridging innovative science with state-of-the-art clinical medicine, to develop PointMan™ assays that can effectively detect treatable cancer mutations in blood samples. The collaboration agreement has been signed following… Read More

Foundation Medicine Partners with the Addario Lung Cancer Medical Institute for Innovative Prospective Study Linking the Genomic Drivers of Lung Cancer in Young Adults with Treatment Options

Posted by Samantha Powell on July 23rd, 2014 |

Foundation Medicine, Inc. (NASDAQ: FMI) today announced that it has partnered with the Addario Lung Cancer Medical Institute (ALCMI) and Bonnie J. Addario Lung Cancer Foundation (ALCF) to launch a first of its kind, multi-center, international prospective study, the Genomics of Young Lung Cancer. This study aims to better inform treatment decisions in young adults… Read More

Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan

Posted by Samantha Powell on July 23rd, 2014 |

Bristol-Myers Squibb Company (NYSE:BMY) and Ono Pharmaceutical Co., Ltd. (“Ono”) have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan. As part of the agreement, Bristol-Myers Squibb and Ono… Read More

Johnson & Johnson Innovation Announces Immuno-Oncology Lung Cancer Collaboration with the Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science

Posted by Samantha Powell on June 23rd, 2014 |

Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. today announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration, Janssen scientists will work with the research team at Dana-Farber’s Belfer Institute for Applied Cancer Science to determine the clinical setting for certain immuno-oncology agents in Janssen’s lung cancer discovery… Read More

Amgen Joins National Cancer Institute, Other Companies On Lung-MAP Project

Posted by Samantha Powell on June 16th, 2014 |

Amgen announced that it will collaborate with the National Cancer Institute and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a clinical trial program that will use biomarker-driven research and genomic profiling to match squamous cell lung cancer patients to investigational treatments based on their individual cancer profiles. In the U.S.,… Read More

Lung-MAP trial launched, matching patients to treatments based on tumor profiles

Posted by Samantha Powell on June 16th, 2014 |

A phase II/III trial using genomic profiling to match patients with investigational treatments began recruiting patients with advanced squamous cell lung cancer on June 16, 2014. The Lung-MAP (Lung Cancer Master Protocol) trial is a public-private collaboration among the National Cancer Institute (NCI), SWOG Cancer Research, Friends of Cancer Research, the Foundation for the National… Read More

Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-drug, Biomarker-driven Clinical Trial for Lung Cancer

Posted by Samantha Powell on June 16th, 2014 |

For further information or inquiries, please contact: Matt Notley Perry Communications [email protected] Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-drug, Biomarker-driven Clinical Trial for Lung Cancer Innovative approach to clinical testing to improve access and ease burden on researchers SAN CARLOS, CA (May 19, 2014) — The Bonnie J Addario Lung Cancer… Read More

The Bonnie J. Addario Lung Cancer Foundation and Cancer Commons Partner to Help Patients Find Their Best Treatment Options

Posted by Samantha Powell on April 21st, 2014 |

Date: 4/21/14 Outlet Full Name: Business Wire Author: No author http://www.businesswire.com/news/home/20140421005147/en/Bonnie-J.-Addario-Lung-Cancer-Foundation-Cancer#.U1VIglVdWVM Bonnie J. Addario Lung Cancer Foundation (ALCF) and Cancer Commons today announced the launch of a new program called MyCancerCommons, created to make sure critical lung cancer treatment information reaches the patients who need it. Lung cancer is the second leading cause of death… Read More

Memorial Cancer Institute Partners with Addario Foundation to Improve Standard of Care for Lung Cancer Patients

Posted by Samantha Powell on March 24th, 2014 |

Date: 3/24/14 Outlet Full Name: Businesswire Author: Matt Notley and Kerting Baldwin http://www.businesswire.com/news/home/20140324005239/en/Memorial-Cancer-Institute-Partners-Addario-Foundation-Improve#.UzBjvqhdXDU The Bonnie J. Addario Lung Cancer Foundation (ALCF) announced today the addition of Memorial Cancer Institute (MCI) in Hollywood, Florida, a part of Memorial Healthcare Systems, to its 360 Community Hospital Centers of Excellence Program, which aims to improve individualized standard of… Read More

Trovagene Launches Pharmaceutical Alliance to Monitor Lung Cancer Patients’ EGFR Mutational Status

Posted by Samantha Powell on October 16th, 2013 |

News Headline:  Trovagene Launches Pharmaceutical Alliance to Monitor Lung Cancer Patients’ EGFR Mutational Status Date:  10/16/13 Outlet Full Name:  News Medical Author:  No Author http://www.news-medical.net/news/20131016/Trovagene-launches-pharmaceutical-alliance-to-monitor-lung-cancer-patients-EGFR-mutational-status.aspx Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene’s proprietary, urine-based, cell-free DNA technology for the detection of… Read More